FDA guidance
Bioresearch Monitoring Technical Conformance Guide
FDA guidance · Final · issued Sep 3, 2024
Key facts
| Title | Bioresearch Monitoring Technical Conformance Guide |
|---|---|
| Status | Final |
| Issue date | Sep 3, 2024 |
| Center | Center for Drug Evaluation and Research |
| Issuing office | Center for Drug Evaluation and Research |
| Communication type | Guidance Document |
| Regulated product | Drugs |
| Topics | Electronic Submissions |
| Docket number | FDA-2018-D-1216 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents